These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18148369)

  • 1. Modified protamine insulin (NPH-50) a clinical report.
    WHITE P
    J Am Med Assoc; 1949 Oct; 141(5):312-4. PubMed ID: 18148369
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
    Zöllner H; Jouni R; Panzer S; Khadour A; Janzen L; Wesche J; Ten Berg M; Schellong S; Heinken A; Greinacher A; Bakchoul T
    J Thromb Haemost; 2017 Jan; 15(1):176-184. PubMed ID: 27759896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.
    Stewart WJ; McSweeney SM; Kellett MA; Faxon DP; Ryan TJ
    Circulation; 1984 Nov; 70(5):788-92. PubMed ID: 6488493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
    Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with a new modified protamine insulin (NPH-50).
    GABRIELE AJ; MARBLE A
    Am J Dig Dis; 1949 Jun; 16(6):197-206. PubMed ID: 18129669
    [No Abstract]   [Full Text] [Related]  

  • 6. Protamine allergy as a complication of insulin hypersensitivity: A case report.
    Bollinger ME; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):462-5. PubMed ID: 10452772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and specificity of protamine antibodies in diabetic and control subjects.
    Nell LJ; Thomas JW
    Diabetes; 1988 Feb; 37(2):172-6. PubMed ID: 3292313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of insulin NPH formulations.
    Norrman M; Hubálek F; Schluckebier G
    Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New form of insulin: crystallized protamine insulin (NPH 50)].
    RUDOLF M
    Concours Med; 1951 Nov; 73(45):3755-7. PubMed ID: 14887229
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes.
    Levy JH; Zaidan JR; Faraj B
    Anesth Analg; 1986 Jul; 65(7):739-42. PubMed ID: 2424341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin with retarded and prolonged action: a new preparation: crystallized protamine insulin NPH 50].
    AUBERTIN E
    J Med Bord; 1951 Jul; 128(7):716-20. PubMed ID: 14861556
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
    Yip CM; Brader ML; Frank BH; DeFelippis MR; Ward MD
    Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
    Yanagisawa K
    Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis to protamine masquerading as an insulin allergy.
    Kim R
    Del Med J; 1993 Jan; 65(1):17-23. PubMed ID: 8454092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine sulfate and NPH insulin.
    Veenendaal M
    Cathet Cardiovasc Diagn; 1988; 15(2):134. PubMed ID: 3180206
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal anaphylactic reaction to protamine after femoropopliteal by-pass surgery.
    Hakala T; Suojaranta-Ylinen R
    Ann Chir Gynaecol; 2000; 89(2):150-2. PubMed ID: 10905682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J; Schreyen H; Dorchy H
    Diabete Metab; 1992; 18(4):272-6. PubMed ID: 1459314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic shock and death associated with protamine administration in a diabetic patient.
    Chu YQ; Cai LJ; Jiang DC; Jia D; Yan SY; Wang YQ
    Clin Ther; 2010 Sep; 32(10):1729-32. PubMed ID: 21194595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.